Spencer Phillips Hey

Author

Also Known As

Charles Weijer, D. Hadfield, Hey, SP, Hey, Spencer, Hey, Spencer Phillips, S Hey, S. Handrean, S. Hey, Spencer Phillips Hey, Spencer Hey

101

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Harvard University Brigham and Women's Hospital Western University McGill University University of Ottawa

About

Spencer Phillips Hey is an author at Harvard University specializing in medicine, medical ethics, and research ethics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Management	3	3	50
2	Education	2	2	158
3	Engineering	2	2	33
4	Health Sciences	2	2	124
5	Law	1	1	18

Spencer Phillips Hey

Publications

Citations

H-Index

Page 1

	Year	Citations
Motivational/solution‐focused intervention improves HbA<sub>1c</sub> in adolescents with Type 1 diabetes: a pilot study Russell Viner, Deborah Christie, Valerie H. Taylor, Diabetic Medicine	2003	143
Evaluating the evidence behind the surrogate measures included in the FDA's table of surrogate endpoints as supporting approval of cancer drugs Bishal Gyawali, Spencer Phillips Hey, Aaron S. Kesselheim EClinicalMedicine	2020	137
Are outcome-adaptive allocation trials ethical? Spencer Phillips Hey, Jonathan Kimmelman Clinical Trials EducationRiskbenefit RatioResearch EthicsClinical TrialsExperimental Economics	2015	105
Countering imprecision in precision medicine Spencer Phillips Hey, Aaron S. Kesselheim Science Evidence-based InterventionComplex InterventionsImplementation ScienceAccuracy And PrecisionLaboratory Medicine	2016	58
Is the concept of clinical equipoise still relevant to research? Spencer Phillips Hey, Alex John London, Charles Weijer, BMJ Biomedical EthicEvidence-based MedicineClinical SpecialtiesEducationResearch Ethics	2017	53
A search filter to identify pragmatic trials in MEDLINE was highly specific but lacked sensitivity Monica Taljaard, Steve McDonald, Stuart G. Nicholls, Journal of Clinical Epidemiology Clinical EffectivenessPatient SafetyClinical TrialsEvidence-based MedicineLacked Sensitivity	2020	46
A Framework for Assessing Scientific Merit in Ethical Review of Clinical Research Ariella Binik, Spencer Phillips Hey Ethics & Human Research Ethics GuidelinesMedical EthicsBiomedical EthicEthic CommitteeScience Ethic	2019	34
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Amr E. Abbas, Fatima Abbas, The Lancet Diabetes & Endocrinology	2023	34
Cell and Gene Therapy Trials: Are We Facing an ‘Evidence Crisis’? Mohamed Abou‐El‐Enein, Spencer Phillips Hey EClinicalMedicine Gene TherapiesGene Therapy TrialsCellular TherapiesIn Vivo Gene TherapyClinical Trials	2019	31
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial Saul N. Faust, Richard Haynes, Christine E. Jones, The Lancet Child & Adolescent Health	2024	31

Page 1